惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Cyber Security Advisories - MS-ISAC
Cyber Security Advisories - MS-ISAC
Webroot Blog
Webroot Blog
U
Unit 42
A
About on SuperTechFans
宝玉的分享
宝玉的分享
月光博客
月光博客
C
CERT Recently Published Vulnerability Notes
P
Privacy International News Feed
Microsoft Security Blog
Microsoft Security Blog
G
Google Developers Blog
P
Privacy & Cybersecurity Law Blog
cs.CL updates on arXiv.org
cs.CL updates on arXiv.org
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
S
Securelist
CTFtime.org: upcoming CTF events
CTFtime.org: upcoming CTF events
Spread Privacy
Spread Privacy
L
Lohrmann on Cybersecurity
Apple Machine Learning Research
Apple Machine Learning Research
K
Kaspersky official blog
Hugging Face - Blog
Hugging Face - Blog
B
Blog
I
Intezer
Last Week in AI
Last Week in AI
T
Threat Research - Cisco Blogs
V
V2EX
L
LangChain Blog
AI
AI
G
GRAHAM CLULEY
T
Tor Project blog
人人都是产品经理
人人都是产品经理
D
Docker
WordPress大学
WordPress大学
Google DeepMind News
Google DeepMind News
I
InfoQ
Y
Y Combinator Blog
C
Comments on: Blog
GbyAI
GbyAI
www.infosecurity-magazine.com
www.infosecurity-magazine.com
酷 壳 – CoolShell
酷 壳 – CoolShell
T
Tailwind CSS Blog
aimingoo的专栏
aimingoo的专栏
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
腾讯CDC
N
News and Events Feed by Topic
MyScale Blog
MyScale Blog
H
Help Net Security
Vercel News
Vercel News
T
Tenable Blog
博客园 - 三生石上(FineUI控件)
爱范儿
爱范儿

Forbes - Healthcare

How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health Doctors Say Hegseth’s Flu Vaccine Decision Will Weaken Military Readiness Where Bullets Fly, Malaria Kills Using AI To Personalize Healthcare–Without Losing Patient Trust Progress For Preeclampsia Allowing Our Military To Refuse Flu Vaccination Is A Bad Idea. Here’s Why Can Vaccine Development Weather Political Storms? A Virus From Farmed Seafood Is Causing A New Eye Disease In People Elevance Health Profits Eclipse $1.7 Billion Despite Elevated Costs The UK Passes A Lifetime Smoking Ban. Could America Be Next? There's No Such Thing As Brain Honey UnitedHealth Group Profits Eclipse $6 Billion As Medical Costs Ease AI Is Already Here. The Real Risk In Public Health Is Sitting It Out UnitedHealthcare Reduces Need For Prior Approvals For Patients In Rural America Why No Child Should Have To Sacrifice School To Care For Their Family Oscar Health Launches Consumer Marketplace For Insurance Beyond Its Own Calling The Iconic 867-5309 Now Goes To A Cancer Helpline FDA Lists Xanax Recall. Here’s What You Need To Know What Trump’s Ibogaine Executive Order Means For Veterans With PTSD 20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs Rotavirus Is Surging Across The US — Here’s What Parents Need To Know Leadership Dysfunctional In Healthcare: “Split The Baby” Thinking ‘Bedtime Stacking’ Trends On TikTok. Here Are The Risks Why Do Weight Loss Drugs Work For Some And Not Others? It’s In The Genes Hospital Safety: How to Avoid Medical Errors and Protect Yourself Medicare Can Save $4 Billion On Four Cancer Drugs — Can You Guess Which Ones? After 25 Years Of Consumer-Directed Healthcare, What’s Missing? This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster RFK Jr. Pushes To Expand Access To Peptides. A Doctor Explains The Risks How The Trump Administration Is Blocking Access To Home Care Genome Sequencing Solves Rare Disease Mysteries Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most New Drug Protects Against Life-Threatening Pancreatitis This Pill May Help Pancreatic Cancer Patients Live Longer What Should We Do When The Patient Is Racist? Attention Turns To UnitedHealth Earnings For Signs Of Insurer Rebound New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know Why Sex Exists A Novel Approach To The Treatment Of Antibiotic Resistant Infections Democrat-Leaning Plan Takes Aim At Health Plans With New Regulations Trump Administration Weighs Default Medicare Advantage Plans For Seniors An AI System Passed Peer Review. The Scientific Community Isn’t Ready Prior Authorization Reform Is Here — And It Could Change How Millions Get Care The More We Add To U.S. Healthcare, The Worse It Gets How Two Sisters Built A $1 Billion HealthTech Unicorn CDC Delays Reporting Of COVID-19 Vaccine Benefits—Here’s What To Know This Startup Wants To Use AI To Help Digitize History Are Nicotine Pouches Like Zyn And VELO Safe To Use? A Doctor Answers America’s Healthcare Innovation Problem GLP-1 Weight Loss Drugs Are Easy To Get—But Are They Safe? Why Cleveland Clinic Chose This AI Startup To Rewire Key Healthcare Operations Upset About The High Price Of Your Hospital Stay? Medicaid Cuts Might Be To Blame Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest A New Way To Target Metastatic Cancer What A Florida Birth Case Reveals About Post-Dobbs Maternal Healthcare 5 Reasons Why the Medicare Program Can’t Go Broke Lowering Healthcare Costs Without A Disastrous Government-Run Model Promising Study Links Coffee Consumption To Reduced Dementia Risk Gene Regulation May Control How Long We Live Health Insurers Get 2.5% Medicare Rate Hike They Feared Would Be Flat Engineered Antibodies Pry Apart The Most Difficult Viruses Centene Latest Health Insurer To Shakeup Management Ranks 1.6 Million Teens Are Vaping. Health Risks Are Worse Than You Think Increasing Burdens Medical Debt And Bankruptcy Are Uniquely American Medicaid Work Requirements Go Live Soon. Here’s How Many Could Lose Coverage What SpaceX’s IPO Means For The Space Economy Thus Far, Most Favored Nation Drug Prices Have Had Little Impact FDA Approves New Oral Weight Loss Pill Foundayo — Here’s What To Know ‘Medicare By Choice’ Plans Could Work, But More Details Needed Criticism of NFL's Rooney Rule Misses How Hiring Actually Works Navigating Health In The Age Of Misinformation NASA Artemis II astronaut health risks explained
Peptide Fad Gripping America Reflects Outsize Role Of Influencers
Joshua P. Cohen · 2026-06-14 · via Forbes - Healthcare
Peptide Therapy

Peptide therapy is popular, thanks in part to the Trump administration's more liberal policy on these treatments. (Photo by Smith Collection/Gado/Getty Images)

Gado via Getty Images

There’s a peptide craze in America. Believed by some to help with healing, recovery and reduction of inflammation, advocates go so far as to suggest peptides can increase longevity. Millions of Americans are currently injecting unapproved chemicals like peptides promoted by hodgepodge of wellness influencers and celebrity podcasters. They are turning to these people for a lot of their health information and even for treatment, often in the form of unproven therapies.

This reflects a larger and perhaps insidious problem in the United States, where there’s been an erosion in trust in public health, in doctors and in the medical profession as a whole.

Roughly half of Americans under 50 get their health information from (wellness) influencers. Here, it appears a libertarian-inspired approach to healthcare has caught on. The “do your own research” crowd suggests people should gather information on remedies, often promoted and used by influencers, to inform choices with respect to which (alternative) treatments to pursue and from whom. From the anti-parasitic ivermectin to psilocybin ("magic mushrooms") to peptides, people are self-treating for a variety of health conditions without professional clinical guidance.

Worldwide, the wellness industry is lucrative, as it’s worth trillions of dollars and is growing substantially. But the risks of taking the wrong substance, dose or combination of products are real.

Furthermore, it’s conspicuous that a Pew Research Center analysis of thousands of large wellness accounts found that only around 40% have a formal medical professional background. The majority are business owners and so-called life coaches. Relying on these sources for health advice and products may not be in the interests of consumers’ well-being.

Peptide Fad

Promoted by influencers and supporters of the “Make America Healthy Again” movement, peptides promise to heal injuries, build muscle and improve sex drive, among other things. But most peptides have limited clinical evidence to support health benefits or demonstrate their safety.

Journalist Sara Talpos wrote a brilliant exposé on peptides in Undark, revealing intriguing facets of peptide-based therapies, including their history and applications. Peptides are short and simple chains of amino acids that are the building blocks of proteins. In the body, they often serve as an inter-cellular communication system. Some peptides are approved for marketing by regulatory authorities like the Food and Drug Administration and taken regularly as medicines by tens of millions of people annually. Examples include insulin for diabetics, as well as GLP-1s such as Ozempic and Wegovy that can be used for weight loss. Others, such as BPC-157, have been embraced by wellness influencers and popular podcasters like Joe Rogan as a treatment for patients seeking relief from health conditions that may not be well-managed with conventional medical treatment.

BPC-157 is a synthetic peptide derived from gastric juice. It’s touted by influencers for its potential to accelerate tissue healing and gut repair. But human data is currently limited to several small studies. And there are concerns regarding possible negative effects of angiogenesis associated with peptides. This is the process through which new blood vessels form from pre-existing ones and is essential for normal cellular growth and wound healing. However, it also plays a role in cancer where it supplies tumors with the oxygen and nutrients needed to grow and spread.

Americans are self-administering unapproved peptides like BPC-157 based on what they see on forums such as Reddit, and generally not from what the advice of their physicians.

MedPage Today reported this week that at the annual meeting of the American Medical Association delegates urged the FDA to do a better job regulating unapproved peptides. The group recommends that unapproved synthetic peptide products, currently being obtained from mostly unregulated sources in the “gray market,” undergo rigorous regulatory review and clinical trials before marketing in proper channels.

Traditionally, the FDA has strongly warned against using unapproved peptides owing to a lack of data from clinical human trials, the risks of allergic reactions and unknown manufacturing impurities, particularly when compounded.

But Health Secretary Robert F. Kennedy Jr. wants to loosen restrictions on experimental medical treatments, including unapproved peptides. And as a top federal government official whose allies include numerous wellness folks, it appears Kennedy is taking the role of unconventional influencer to the next level.